Sugar Maple Asset Management, LLC Aquestive Therapeutics, Inc. Transaction History
Sugar Maple Asset Management, LLC
- $122 Million
- Q3 2025
A detailed history of Sugar Maple Asset Management, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Sugar Maple Asset Management, LLC holds 12,000 shares of AQST stock, worth $72,960. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,000
Previous 12,000
-0.0%
Holding current value
$72,960
Previous $39,000
71.79%
% of portfolio
0.05%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
133Shares Held
49.4MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$59.7 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$33.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$26.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$18.1 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$13.3 Million0.32% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $324M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...